biotech news today glp-1 What's next for innovation: A primer on the race reshaping pharma and chronic disease care FDA approves first GLP-1 pill

Their findings highlight a crucial MGBA in which intestinal immune modulation directly influences the severity of ischemic brain injury (Benakis et al., 2016)

Such treatment, however, often failed, leaving patients with no option but to undergo surgery

Allergens: None As a leader in the nutritional supplement category for over 10 years, Applied Nutrition has offered the highest quality products in the weight loss, cleansing, sexual health and targeted nutrition categories

2025) Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study

Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine